🇺🇸 FDA
Patent

US 11964018

Therapeutic uses for sodium thiosulfate formulations

granted A61KA61K33/04A61K33/243

Quick answer

US patent 11964018 (Therapeutic uses for sodium thiosulfate formulations) held by Fennec Pharmaceuticals, Inc. expires Mon Apr 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Fennec Pharmaceuticals, Inc.
Grant date
Tue Apr 23 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61K, A61K33/04, A61K33/243, A61K47/02, A61K47/18